Search

everythinglearnresearchcommunity

for

Search:↓

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Oophorectomy reduces ovarian cancer risk for women with BRCA mutations, finasteride lowers prostate cancer risk without raising death risk, and prophylactic mastectomy rates are rising.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

An 81-year-old woman's severe male hormone symptoms were caused by an ovarian tumor, which was treated with surgery.

Both contraceptive pill doses effectively reduced androgen levels in women with PCOS.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

5-Alpha-Reductase Inhibitors can cause negative side effects.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Natural herbal compounds might treat certain medical conditions by reducing DHT levels, but more research is needed to confirm their effectiveness and safety.

A postmenopausal woman's excessive hair growth and hair loss were due to a non-cancerous ovarian condition, treated successfully with surgery.

Lysocellin helps stop cell damage from etoposide and may prevent hair loss.

Birth control pills are effective for treating women with too much male hormone.

Kuntai capsules combined with nilestriol tablets effectively reduce perimenopausal symptoms and improve hormone levels.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Androgens are important for normal ovarian function and estrogen production, but may not be the main cause of follicle death.

Hair loss can occur as a side effect of certain breast cancer treatments, but minoxidil can help regrow hair.

Thorough evaluation is crucial for postmenopausal women with virilization to detect rare ovarian tumors.

An ovarian tumor can cause high male hormones in postmenopausal women.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Estrogen may help improve COVID-19 outcomes, especially in women.

Dexamethasone may influence hair growth by altering estrogen receptor activity in hair cells.

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

Postmenopausal women with excess male hormones may have ovarian tumors, and surgery usually cures them.

5α-reductase inhibitors like finasteride may not be effective or safe for transgender individuals, and more research is needed.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Etifoxine, an anxiety drug, can lessen brain inflammation and cognitive issues in mice, partly by increasing production of protective brain steroids.

Doxazosin may cause breast enlargement and pain in men.

Menopausal hormone therapy is best for hot flashes, while other options include SSRIs, SNRIs, fezolinetant, and lifestyle changes.